188 related articles for article (PubMed ID: 11510923)
1. Antineuronal nuclei immunohistochemical staining patterns in childhood ependymomas.
Parker JR; Armstrong DL; Strother D; Rudman DM; Dauser RC; Laurent JP; Deyd J; Rouah PE
J Child Neurol; 2001 Aug; 16(8):548-52. PubMed ID: 11510923
[TBL] [Abstract][Full Text] [Related]
2. Molecular markers of primitive neuroectodermal tumors and other pediatric central nervous system tumors. Monoclonal antibodies to neuronal and glial antigens distinguish subsets of primitive neuroectodermal tumors.
Molenaar WM; Jansson DS; Gould VE; Rorke LB; Franke WW; Lee VM; Packer RJ; Trojanowski JQ
Lab Invest; 1989 Dec; 61(6):635-43. PubMed ID: 2557487
[TBL] [Abstract][Full Text] [Related]
3. Sensitivity and specificity of epithelial membrane antigen staining patterns in ependymomas.
Hasselblatt M; Paulus W
Acta Neuropathol; 2003 Oct; 106(4):385-8. PubMed ID: 12898159
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-1 alpha (IL-1 alpha), IL-1 beta, IL-1 receptor type I, IL-1 receptor antagonist, and TGF-beta 1 mRNAs in pediatric astrocytomas, ependymomas, and primitive neuroectodermal tumors.
Ilyin SE; González-Gómez I; Gilles FH; Plata-Salamán CR
Mol Chem Neuropathol; 1998 Feb; 33(2):125-37. PubMed ID: 9565970
[TBL] [Abstract][Full Text] [Related]
5. OLIG2 is a useful immunohistochemical marker in differential diagnosis of clear cell primary CNS neoplasms.
Preusser M; Budka H; Rössler K; Hainfellner JA
Histopathology; 2007 Feb; 50(3):365-70. PubMed ID: 17257132
[TBL] [Abstract][Full Text] [Related]
6. Identification of novel biomarkers in pediatric primitive neuroectodermal tumors and ependymomas by proteome-wide analysis.
de Bont JM; den Boer ML; Kros JM; Passier MM; Reddingius RE; Smitt PA; Luider TM; Pieters R
J Neuropathol Exp Neurol; 2007 Jun; 66(6):505-16. PubMed ID: 17549010
[TBL] [Abstract][Full Text] [Related]
7. The immunophenotype of ependymomas.
Vege KD; Giannini C; Scheithauer BW
Appl Immunohistochem Mol Morphol; 2000 Mar; 8(1):25-31. PubMed ID: 10937045
[TBL] [Abstract][Full Text] [Related]
8. Supratentorial primitive neuroectodermal tumours of the brain: multidirectional differentiation does not influence prognosis. A clinicopathological report of 18 patients.
Visée S; Soltner C; Rialland X; Machet MC; Loussouarn D; Milinkevitch S; Pasco-Papon A; Mercier P; Rousselet MC
Histopathology; 2005 Apr; 46(4):403-12. PubMed ID: 15810952
[TBL] [Abstract][Full Text] [Related]
9. Anaplastic ependymoma with ependymoblastic multilayered rosettes.
Nobusawa S; Suzuki A; Nagaishi M; Isoda K; Ikota H; Yokoo H; Hirato J; Nakazato Y
Hum Pathol; 2013 Nov; 44(11):2597-602. PubMed ID: 23791209
[TBL] [Abstract][Full Text] [Related]
10. [Primitive neuroectodermal tumor of central nervous system with features of ependymoblastoma and neuroblastoma: a clinicopathologic study of 4 cases].
Wang R; Guan W; Wu X; Zhang W; Jiang B; Ma J; Wang L
Zhonghua Bing Li Xue Za Zhi; 2014 Jun; 43(6):403-7. PubMed ID: 25208992
[TBL] [Abstract][Full Text] [Related]
11. [Diagnostic use of D2-40 and annexin-1 in ependymal tumors].
Wang YF; Piao YS; Lu DH; Chen L; Wang W; Yang H; Wei LF
Zhonghua Bing Li Xue Za Zhi; 2011 Sep; 40(9):595-8. PubMed ID: 22177242
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical analysis of INI1 protein in malignant pediatric CNS tumors: Lack of INI1 in atypical teratoid/rhabdoid tumors and in a fraction of primitive neuroectodermal tumors without rhabdoid phenotype.
Haberler C; Laggner U; Slavc I; Czech T; Ambros IM; Ambros PF; Budka H; Hainfellner JA
Am J Surg Pathol; 2006 Nov; 30(11):1462-8. PubMed ID: 17063089
[TBL] [Abstract][Full Text] [Related]
13. Correlation of bcl-2, p53, and MIB-1 expression with ependymoma grade and subtype.
Rushing EJ; Brown DF; Hladik CL; Risser RC; Mickey BE; White CL
Mod Pathol; 1998 May; 11(5):464-70. PubMed ID: 9619600
[TBL] [Abstract][Full Text] [Related]
14. Expression of cyclo-oxygenase-2 in ependymal tumors.
Roma AA; Prayson RA
Neuropathology; 2006 Oct; 26(5):422-8. PubMed ID: 17080719
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical study of ependymal neoplasms: histological subtypes and glial and epithelial characteristics.
Kaneko Y; Takeshita I; Matsushima T; Iwaki T; Tashima T; Fukui M
Virchows Arch A Pathol Anat Histopathol; 1990; 417(2):97-103. PubMed ID: 1695040
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical detection of nestin in pediatric brain tumors.
Almqvist PM; Mah R; Lendahl U; Jacobsson B; Hendson G
J Histochem Cytochem; 2002 Feb; 50(2):147-58. PubMed ID: 11799134
[TBL] [Abstract][Full Text] [Related]
17. Expression of alpha-, beta-, and gamma-synuclein in glial tumors and medulloblastomas.
Fung KM; Rorke LB; Giasson B; Lee VM; Trojanowski JQ
Acta Neuropathol; 2003 Aug; 106(2):167-75. PubMed ID: 12783249
[TBL] [Abstract][Full Text] [Related]
18. CD99 immunoreactivity in ependymoma.
Choi YL; Chi JG; Suh YL
Appl Immunohistochem Mol Morphol; 2001 Jun; 9(2):125-9. PubMed ID: 11396629
[TBL] [Abstract][Full Text] [Related]
19. Patterns of reactivity with anti-glycolipid antibodies in human primary brain tumors.
Li J; Pearl DK; Pfeiffer SE; Yates AJ
J Neurosci Res; 1994 Oct; 39(2):148-58. PubMed ID: 7530777
[TBL] [Abstract][Full Text] [Related]
20. Identification of relevant prognostic histopathologic features in 69 intracranial ependymomas, excluding myxopapillary ependymomas and subependymomas.
Kurt E; Zheng PP; Hop WC; van der Weiden M; Bol M; van den Bent MJ; Avezaat CJ; Kros JM
Cancer; 2006 Jan; 106(2):388-95. PubMed ID: 16342252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]